Jaw-Ming Cherng Selected Research

2-methoxycinnamaldehyde

1/2017	Cinnamomum verum ingredient 2-methoxycinnamaldehyde: a new antiproliferative drug targeting topoisomerase I and II in human lung squamous cell carcinoma NCI-H520 cells.
2/2016	Cinnamomum verum Component 2-Methoxycinnamaldehyde: A Novel Anticancer Agent with Both Anti-Topoisomerase I and II Activities in Human Lung Adenocarcinoma A549 Cells In Vitro and In Vivo.
1/2016	Discovery of a novel anticancer agent with both anti-topoisomerase I and II activities in hepatocellular carcinoma SK-Hep-1 cells in vitro and in vivo: Cinnamomum verum component 2-methoxycinnamaldehyde.
1/2016	Cinnamomum verum component 2-methoxycinnamaldehyde: a novel antiproliferative drug inducing cell death through targeting both topoisomerase I and II in human colorectal adenocarcinoma COLO 205 cells.
1/2016	Discovery of a novel anti-cancer agent targeting both topoisomerase I and II in hepatocellular carcinoma Hep 3B cells in vitro and in vivo: Cinnamomum verum component 2-methoxycinnamaldehyde.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jaw-Ming Cherng Research Topics

Disease

9	Carcinogenesis 01/2017 - 06/2011
8	Neoplasms (Cancer) 05/2016 - 06/2007
3	Sunburn 01/2012 - 06/2011
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017 - 01/2016
2	Adenocarcinoma 05/2016 - 01/2016
2	Adenocarcinoma of Lung 02/2016 - 01/2016
2	Hepatocellular Carcinoma (Hepatoma) 01/2016 - 01/2016
2	Skin Neoplasms (Skin Cancer) 01/2012 - 06/2011
2	Nasopharyngeal Carcinoma 12/2005 - 07/2004
1	Virus Diseases (Viral Diseases) 01/2016
1	Skin Diseases (Skin Disease) 01/2016
1	Lymphadenopathy 01/2016
1	Stroke (Strokes) 01/2016
1	Dyspepsia (Indigestion) 01/2016
1	Elephantiasis 01/2016
1	Rheumatic Diseases (Rheumatism) 01/2016
1	Emphysema 04/2013
1	Inflammation (Inflammations) 08/2011
1	Epstein-Barr Virus Infections 07/2008
1	Pleural Effusion (Pleural Effusions) 09/2007
1	Carcinoma (Carcinomatosis) 06/2007
1	Hypertension (High Blood Pressure) 03/2002

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 01/2017 - 06/2011
6	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2017 - 01/2016
5	2-methoxycinnamaldehydeIBA 01/2017 - 01/2016
3	cuminaldehydeIBA 05/2016 - 01/2016
3	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2012 - 06/2011
3	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 01/2012 - 06/2011
3	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2012 - 06/2011
3	Pyrimidine DimersIBA 01/2012 - 06/2011
2	Antineoplastic Agents (Antineoplastics)IBA 02/2016 - 01/2016
2	Glycyrrhizic Acid (Glycyrrhizin)IBA 08/2011 - 07/2008
2	Membrane Proteins (Integral Membrane Proteins)IBA 12/2005 - 07/2004
2	EpitopesIBA 12/2005 - 07/2004
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	Plant ExtractsIBA 01/2016
1	C-Reactive ProteinIBA 04/2013
1	CurcuminIBA 01/2012
1	Transcription Factors (Transcription Factor)IBA 08/2011
1	Antiviral Agents (Antivirals)IBA 08/2011
1	Dinoprostone (PGE2)FDA Link 08/2011
1	amsonic acid (DAS)IBA 06/2011
1	allyl sulfideIBA 06/2011
1	HLA-DR Antigens (HLA-DR)IBA 11/2009
1	DNA (Deoxyribonucleic Acid)IBA 07/2008
1	Viral AntigensIBA 07/2008
1	GasesIBA 09/2007
1	FlavonoidsIBA 06/2007
1	baicaleinIBA 06/2007
1	linaloolIBA 06/2007
1	LuteolinIBA 06/2007
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2005
1	Amino Acids FDA Link 07/2004
1	AngiotensinogenIBA 03/2002
1	GuanineIBA 03/2002
1	Adenine FDA LinkGeneric 03/2002